Development of molecular-targeted bubbles based on clinically available ultrasound contrast agent
| Project/Area Number |
23700591
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Medical systems
|
|---|
| Research Institution | National Cardiovascular Center Research Institute |
|---|
Principal Investigator |
OTANI Kentaro 独立行政法人国立循環器病研究センター, 研究所, 研究員 (50470191)
|
|---|
| Project Period (FY) |
2011 – 2013
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2012: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
|---|
| Keywords | マイクロ・ナノデバイス / 生体分子 / 超音波 / 分子イメージング / 薬学 |
|---|
| Research Abstract |
In the present study, we developed the preparation method of targeted-bubbles for ultrasound molecular imaging based on clinically available ultrasound contrast agent, Sonazoid. By modifying Sonazoid with lactadherin, the number of adhered bubbles to integrin avb3-expresssing endothelial cells was increased significantly. Our results would imply the feasibility of lactadherin-bearing Sonazoid as ultrasound contrast agent for angiogenesis. The future in vivo studies would be of benefit.
|
Report
(4 results)
Research Products
(15 results)
